Cormorant Asset Management, LP

Holdings History for REATA PHARMACEUTICALS INC - CL A (RETA)

Symbol: RETA
Investment type: Equity / CL A

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2021			-0.41%	$0	0	-100,000	-100%		Q4 2021
30 Sep 2021		0.41%	-0.28%	$10,061,000	100,000	-68,150	-41%	$100.61	Q3 2021
30 Jun 2021		0.93%	-1.3%	$23,798,000	168,150	-231,850	-58%	$141.53	Q2 2021
31 Mar 2021		1.1%	-0.29%	$39,880,000	400,000	-100,000	-20%	$99.70	Q1 2021
31 Dec 2020		1.8%	+0.18%	$61,810,000	500,000	+50,000	+11%	$123.62	Q4 2020
30 Sep 2020		1.9%	+0.21%	$43,839,000	450,000	+50,000	+12%	$97.42	Q3 2020
30 Jun 2020		2.7%	-0.6%	$62,408,000	400,000	-87,206	-18%	$156.02	Q2 2020
30 Jun 2020	call		-9.1%	$0	0	-250,000	-100%		Q2 2020
31 Mar 2020		4%	-2.7%	$70,323,000	487,206	-329,194	-40%	$144.34	Q1 2020
31 Mar 2020	call	9.1%	0%	$36,085,000	250,000	0		$144.34	Q1 2020
31 Dec 2019		7.3%	-0.03%	$166,897,000	816,400	-3,369	-0.41%	$204.43	Q4 2019
31 Dec 2019	call	22%	+22%	$51,108,000	250,000	+250,000	NEW	$204.43	Q4 2019
30 Sep 2019		4.8%	+0.08%	$65,819,000	819,769	+13,619	+1.7%	$80.29	Q3 2019
30 Jun 2019		4.8%	+1.1%	$76,060,000	806,150	+191,150	+31%	$94.35	Q2 2019
31 Mar 2019		3.8%	-0.36%	$52,564,000	615,000	-59,251	-8.8%	$85.47	Q1 2019
31 Dec 2018		3.4%	+0.07%	$37,825,000	674,251	+14,251	+2.2%	$56.10	Q4 2018
30 Sep 2018		3.9%	+1.2%	$53,962,000	660,000	+210,000	+47%	$81.76	Q3 2018
30 Jun 2018		1.3%	0%	$15,737,000	450,000	0		$34.97	Q2 2018
31 Mar 2018		0.8%	+0.44%	$9,230,000	450,000	+250,000	+125%	$20.51	Q1 2018
31 Dec 2017		0.66%	-0.62%	$5,664,000	200,000	-188,574	-49%	$28.32	Q4 2017
30 Sep 2017		2.1%	+2.1%	$12,085,000	388,574	+388,574	NEW	$31.10	Q3 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.